Glaxosmithkline Plc Adr Stock Price on February 18, 2020

GSK Stock  USD 42.99  0.20  0.47%   
Below is the normalized historical share price chart for GlaxoSmithKline PLC ADR extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of GlaxoSmithKline PLC stands at 42.99, as last reported on the 28th of March, with the highest price reaching 43.03 and the lowest price hitting 42.51 during the day.
IPO Date
9th of July 1986
200 Day MA
37.278
50 Day MA
41.5174
Beta
0.261
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in GlaxoSmithKline Stock, it is important to understand the factors that can impact its price. GlaxoSmithKline PLC appears to be very steady, given 3 months investment horizon. GlaxoSmithKline PLC ADR holds Efficiency (Sharpe) Ratio of 0.27, which attests that the entity had a 0.27% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for GlaxoSmithKline PLC ADR, which you can use to evaluate the volatility of the firm. Please utilize GlaxoSmithKline PLC's risk adjusted performance of 0.1527, and Market Risk Adjusted Performance of 1.72 to validate if our risk estimates are consistent with your expectations.
  
At this time, GlaxoSmithKline PLC's Total Stockholder Equity is quite stable compared to the past year. Common Stock Total Equity is expected to rise to about 1.6 B this year, although the value of Common Stock will most likely fall to about 1.3 B. . At this time, GlaxoSmithKline PLC's Price Fair Value is quite stable compared to the past year. GlaxoSmithKline Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.2673

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsGSK
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 0.99
  actual daily
8
92% of assets are more volatile

Expected Return

 0.26
  actual daily
5
95% of assets have higher returns

Risk-Adjusted Return

 0.27
  actual daily
20
80% of assets perform better
Based on monthly moving average GlaxoSmithKline PLC is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GlaxoSmithKline PLC by adding it to a well-diversified portfolio.
Price Book
5.1995
Enterprise Value Ebitda
11.4638
Price Sales
2.8943
Shares Float
3.9 B
Dividend Share
0.58

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About GlaxoSmithKline PLC Stock history

GlaxoSmithKline PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GlaxoSmithKline is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GlaxoSmithKline PLC ADR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GlaxoSmithKline PLC stock prices may prove useful in developing a viable investing in GlaxoSmithKline PLC
Last ReportedProjected for 2024
Common Stock Shares Outstanding4.1 B4.3 B
Net Income Applicable To Common Shares13.5 B14.1 B

GlaxoSmithKline PLC Stock Technical Analysis

GlaxoSmithKline PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of GlaxoSmithKline PLC technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of GlaxoSmithKline PLC trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

GlaxoSmithKline PLC Period Price Range

GlaxoSmithKline PLC March 28, 2024 Market Strength

Market strength indicators help investors to evaluate how GlaxoSmithKline PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GlaxoSmithKline PLC shares will generate the highest return on investment. By undertsting and applying GlaxoSmithKline PLC stock market strength indicators, traders can identify GlaxoSmithKline PLC ADR entry and exit signals to maximize returns

GlaxoSmithKline PLC Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for GlaxoSmithKline PLC's price direction in advance. Along with the technical and fundamental analysis of GlaxoSmithKline Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of GlaxoSmithKline to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether GlaxoSmithKline PLC ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlaxoSmithKline Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glaxosmithkline Plc Adr Stock. Highlighted below are key reports to facilitate an investment decision about Glaxosmithkline Plc Adr Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for GlaxoSmithKline Stock analysis

When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
0.58
Earnings Share
3.02
Revenue Per Share
14.97
Quarterly Revenue Growth
0.092
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.